摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-[5-(4-methoxyphenyl)-4,5-dihydro-isoxazol-3-yl]-4-methyl-piperidine | 1130365-62-6

中文名称
——
中文别名
——
英文名称
1-[5-(4-methoxyphenyl)-4,5-dihydro-isoxazol-3-yl]-4-methyl-piperidine
英文别名
5-(4-Methoxyphenyl)-3-(4-methylpiperidin-1-yl)-4,5-dihydro-1,2-oxazole;5-(4-methoxyphenyl)-3-(4-methylpiperidin-1-yl)-4,5-dihydro-1,2-oxazole
1-[5-(4-methoxyphenyl)-4,5-dihydro-isoxazol-3-yl]-4-methyl-piperidine化学式
CAS
1130365-62-6
化学式
C16H22N2O2
mdl
——
分子量
274.363
InChiKey
CDIDESSKXNEJQZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.6
  • 重原子数:
    20
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.56
  • 拓扑面积:
    34.1
  • 氢给体数:
    0
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1-[5-(4-methoxyphenyl)-4,5-dihydro-isoxazol-3-yl]-4-methyl-piperidine咪唑 作用下, 以 甲苯 为溶剂, 反应 5.0h, 以84%的产率得到4-methyl-1-[5-(4-methoxyphenyl)-isoxazol-3-yl]-piperidine
    参考文献:
    名称:
    Synthesis of 3-Aminoisoxazoles via the Addition−Elimination of Amines on 3-Bromoisoxazolines
    摘要:
    A novel two-step procedure for the synthesis of 3-amino-5-substituted-isoxazoles Is described. In the presence of a base, readily available 3-bromoisoxazolines react with amines to afford 3-aminoisoxazolines. An oxidation protocol was developed for these heterocycles to provide 3-aminoisoxazoles in consistently high yield.
    DOI:
    10.1021/ol9000284
  • 作为产物:
    描述:
    4-甲基哌啶3-bromo-5-(4-methoxyphenyl)-4,5-dihydroisoxazole 在 sodium carbonate 作用下, 以 正丁醇 为溶剂, 反应 1.0h, 以100%的产率得到1-[5-(4-methoxyphenyl)-4,5-dihydro-isoxazol-3-yl]-4-methyl-piperidine
    参考文献:
    名称:
    Synthesis of 3-Aminoisoxazoles via the Addition−Elimination of Amines on 3-Bromoisoxazolines
    摘要:
    A novel two-step procedure for the synthesis of 3-amino-5-substituted-isoxazoles Is described. In the presence of a base, readily available 3-bromoisoxazolines react with amines to afford 3-aminoisoxazolines. An oxidation protocol was developed for these heterocycles to provide 3-aminoisoxazoles in consistently high yield.
    DOI:
    10.1021/ol9000284
点击查看最新优质反应信息

文献信息

  • [EN] ISOXAZOLINES AS INHIBITORS OF FATTY ACID AMIDE HYDROLASE<br/>[FR] ISOXAZOLINES EN TANT QU'INHIBITEURS DE L'HYDROLASE DES AMIDES D'ACIDES GRAS
    申请人:INFINITY PHARMACEUTICALS INC
    公开号:WO2010135360A1
    公开(公告)日:2010-11-25
    The present invention provides isoxazoline FAAH inhibitors of the formula (I): or pharmaceutically acceptable forms thereof, wherein each of G, Ra, Rb, Rc, and Rd are as defined herein. The present invention also provides pharmaceutical compositions comprising a compound of formula (I), or a pharmaceutically acceptable form thereof, and a pharmaceutically acceptable excipient. The present invention also provides methods for treating an FAAH-mediated condition comprising administering a therapeutically effective amount of a compound of formula (I), or pharmaceutically acceptable form thereof, to a subject in need thereof.
    本发明提供了式(I)的异噁唑啉FAAH抑制剂或其药用可接受形式,其中G、Ra、Rb、Rc和Rd中的每一个如本文所定义。本发明还提供了包括式(I)化合物或其药用可接受形式以及药用可接受赋形剂的药物组合物。本发明还提供了治疗FAAH介导疾病的方法,包括向需要的受试者施用式(I)化合物或其药用可接受形式的治疗有效量。
  • ISOXAZOLINES AS INHIBITORS OF FATTY ACID AMIDE HYDROLASE
    申请人:Behnke Mark L.
    公开号:US20110028478A1
    公开(公告)日:2011-02-03
    The present invention provides isoxazoline FAAH inhibitors of the formula (I): or pharmaceutically acceptable forms thereof, wherein each of G, R a , R b , R c , and R d are as defined herein. The present invention also provides pharmaceutical compositions comprising a compound of formula (I), or a pharmaceutically acceptable form thereof, and a pharmaceutically acceptable excipient. The present invention also provides methods for treating an FAAH-mediated condition comprising administering a therapeutically effective amount of a compound of formula (I), or pharmaceutically acceptable form thereof, to a subject in need thereof.
    本发明提供了式(I)的异噁唑烷FAAH抑制剂或其药学上可接受的形式,其中G、Ra、Rb、Rc和Rd的定义如本文所述。本发明还提供了包括式(I)化合物或其药学上可接受的形式和药学上可接受的赋形剂的制药组合物。本发明还提供了治疗FAAH介导的疾病的方法,包括向需要治疗的患者施用式(I)化合物或其药学上可接受的形式的治疗有效量。
  • US9149465B2
    申请人:——
    公开号:US9149465B2
    公开(公告)日:2015-10-06
  • Synthesis of 3-Aminoisoxazoles via the Addition−Elimination of Amines on 3-Bromoisoxazolines
    作者:Mélina Girardin、Pamela G. Alsabeh、Sophie Lauzon、Sarah J. Dolman、Stéphane G. Ouellet、Greg Hughes
    DOI:10.1021/ol9000284
    日期:2009.3.5
    A novel two-step procedure for the synthesis of 3-amino-5-substituted-isoxazoles Is described. In the presence of a base, readily available 3-bromoisoxazolines react with amines to afford 3-aminoisoxazolines. An oxidation protocol was developed for these heterocycles to provide 3-aminoisoxazoles in consistently high yield.
查看更多